查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1322222

自動注射器市場 - 2023-2031 年全球行業分析、規模、佔有率、成長、趨勢和預測

Autoinjectors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 2-10個工作天內

價格

自動注射器市場 - 報告範圍

TMR 關於全球自動注射器市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了該期間全球自動注射器市場的收入2017-2031年，以2023年為基準年，2031年為預測年。該報告還提供了2023年至2031年全球自動注射器市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領袖和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解自動注射器市場。

該報告深入研究了全球自動注射器市場的競爭格局。全球自動注射器市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球自動注射器市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設和研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 疾病發病率和患病率
  • 概述：未來
  • 監管分析
  • COVID-19 影響分析

第 6 章：全球市場分析與預測：按類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按類型，2017-2031
    • 拋棄式的
    • 可重複使用的
  • 市場吸引力分析：按類型

第 7 章：全球市場分析與預測：按技術分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按技術分類，2017-2031
    • 手持式
    • 穿戴式
  • 市場吸引力分析：按技術分類

第 8 章：全球市場分析與預測：按管理途徑

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按給藥途徑，2017-2031
    • 皮下
    • 肌肉注射
  • 市場吸引力分析：按給藥途徑

第 9 章：全球市場分析與預測：按指標分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按指標分類，2017-2031
    • 多發性硬化症
    • 類風濕關節炎
    • 糖尿病
    • 過敏反應
    • 其他
  • 市場吸引力分析：按指標分類

第 10 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 家庭護理設置
    • 醫院和診所
  • 市場吸引力分析：按最終用戶

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 12 章：北美市場分析與預測

第 13 章：歐洲市場分析與預測

第 14 章：亞太市場分析與預測

第 15 章：拉丁美洲市場分析與預測

第 16 章：中東和非洲市場分析與預測

第17章：競爭格局

  • 市場參與者 - 競爭矩陣（按公司層級和規模）
  • 公司市場佔有率分析 (2022)
  • 公司簡介
    • Ypsomed Holding AG
    • Novartis AG
    • BD
    • Medmix Healthcare
    • Eli Lilly and Company
    • Sanofi
    • Mylan NV
    • Amgen Inc.
    • SHL Medical AG
    • Recipharm AB
Product Code: TMRGL85651

Autoinjectors Market - Scope of Report

TMR's report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Autoinjectors Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Autoinjectors Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Autoinjectors Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Autoinjectors Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Autoinjectors Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Autoinjectors Market.

The report delves into the competitive landscape of the global Autoinjectors Market. Key players operating in the global Autoinjectors Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Autoinjectors Market profiled in this report.

Key Questions Answered in Global Autoinjectors Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Autoinjectors Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Autoinjectors Market - Research Objectives and Research Approach

The comprehensive report on the global Autoinjectors Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Autoinjectors Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Autoinjectors.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Autoinjectors Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Disease Incidence and Prevalence
  • 5.3. Overview: Future of Autoinjectors
  • 5.4. Regulatory Analysis
  • 5.5. COVID-19 Impact Analysis

6. Global Autoinjectors Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Disposable
    • 6.3.2. Reusable
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Autoinjectors Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Handheld
    • 7.3.2. Wearable
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Subcutaneous
    • 8.3.2. Intramuscular
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Autoinjectors Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Multiple Sclerosis
    • 9.3.2. Rheumatoid Arthritis
    • 9.3.3. Diabetes
    • 9.3.4. Anaphylaxsis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Autoinjectors Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Homecare Settings
    • 10.3.2. Hospitals & Clinics
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Autoinjectors Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Autoinjectors Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Disposable
    • 12.2.2. Reusable
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. Handheld
    • 12.3.2. Wearable
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Subcutaneous
    • 12.4.2. Intramuscular
  • 12.5. Market Value Forecast, by Indication, 2017-2031
    • 12.5.1. Multiple Sclerosis
    • 12.5.2. Rheumatoid Arthritis
    • 12.5.3. Diabetes
    • 12.5.4. Anaphylaxsis
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by End-user, 2017-2031
    • 12.6.1. Homecare Settings
    • 12.6.2. Hospitals & Clinics
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Technology
    • 12.8.3. By Route of Administration
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Autoinjectors Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Disposable
    • 13.2.2. Reusable
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. Handheld
    • 13.3.2. Wearable
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Subcutaneous
    • 13.4.2. Intramuscular
  • 13.5. Market Value Forecast, by Indication, 2017-2031
    • 13.5.1. Multiple Sclerosis
    • 13.5.2. Rheumatoid Arthritis
    • 13.5.3. Diabetes
    • 13.5.4. Anaphylaxsis
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by End-user, 2017-2031
    • 13.6.1. Homecare Settings
    • 13.6.2. Hospitals & Clinics
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Technology
    • 13.8.3. By Route of Administration
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Autoinjectors Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Disposable
    • 14.2.2. Reusable
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. Handheld
    • 14.3.2. Wearable
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Subcutaneous
    • 14.4.2. Intramuscular
  • 14.5. Market Value Forecast, by Indication, 2017-2031
    • 14.5.1. Multiple Sclerosis
    • 14.5.2. Rheumatoid Arthritis
    • 14.5.3. Diabetes
    • 14.5.4. Anaphylaxsis
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by End-user, 2017-2031
    • 14.6.1. Homecare Settings
    • 14.6.2. Hospitals & Clinics
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Route of Administration
    • 14.8.3. By Technology
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Autoinjectors Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2031
    • 15.2.1. Disposable
    • 15.2.2. Reusable
  • 15.3. Market Value Forecast, by Technology, 2017-2031
    • 15.3.1. Handheld
    • 15.3.2. Wearable
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Subcutaneous
    • 15.4.2. Intramuscular
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Multiple Sclerosis
    • 15.5.2. Rheumatoid Arthritis
    • 15.5.3. Diabetes
    • 15.5.4. Anaphylaxsis
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by End-user, 2017-2031
    • 15.6.1. Homecare Settings
    • 15.6.2. Hospitals & Clinics
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Technology
    • 15.8.3. By Route of Administration
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Autoinjectors Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2017-2031
    • 16.2.1. Disposable
    • 16.2.2. Reusable
  • 16.3. Market Value Forecast, by Technology, 2017-2031
    • 16.3.1. Handheld
    • 16.3.2. Wearable
  • 16.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 16.4.1. Subcutaneous
    • 16.4.2. Intramuscular
  • 16.5. Market Value Forecast, by Indication, 2017-2031
    • 16.5.1. Multiple Sclerosis
    • 16.5.2. Rheumatoid Arthritis
    • 16.5.3. Diabetes
    • 16.5.4. Anaphylaxsis
    • 16.5.5. Others
  • 16.6. Market Value Forecast, by End-user, 2017-2031
    • 16.6.1. Homecare Settings
    • 16.6.2. Hospitals & Clinics
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Technology
    • 16.8.3. By Route of Administration
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Ypsomed Holding AG
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Novartis AG
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.4. Recent Developments
    • 17.3.3. BD
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Medmix Healthcare
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eli Lilly and Company
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Sanofi
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Mylan N.V.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Amgen Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. SHL Medical AG
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Recipharm AB
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments

List of Tables

  • Table 01: Global Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 04: Global Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 05: Global Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Autoinjectors Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Autoinjectors Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 09: North America Autoinjectors Market (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: North America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 12: North America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 17: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 18: Europe Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 23: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 24: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 27: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Technology 2017-2031
  • Table 28: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 29: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 35: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 36: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Autoinjectors Market Value Share, by Type, 2022
  • Figure 03: Global Autoinjectors Market Value Share, by Technology, 2022
  • Figure 04: Global Autoinjectors Market Value Share, by Indication, 2022
  • Figure 05: Global Autoinjectors Market Value Share, by Route of Administration, 2022
  • Figure 06: Global Autoinjectors Market Value Share, by End-user, 2022
  • Figure 07: Global Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 08: Global Autoinjectors Market Revenue (US$ Mn), by Disposable, 2017-2031
  • Figure 09: Global Autoinjectors Market Revenue (US$ Mn), by Reusable, 2017-2031
  • Figure 10: Global Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 11: Global Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 12: Global Autoinjectors Market Revenue (US$ Mn), by Handheld, 2017-2031
  • Figure 13: Global Autoinjectors Market Revenue (US$ Mn), by Wearable, 2017-2031
  • Figure 14: Global Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 15: Global Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 16: Global Autoinjectors Market Revenue (US$ Mn), by Subcutaneous, 2017-2031
  • Figure 17: Global Autoinjectors Market Revenue (US$ Mn), by Intramuscular, 2017-2031
  • Figure 18: Global Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 19: Global Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 20: Global Autoinjectors Market Revenue (US$ Mn), by Multiple Sclerosis, 2017-2031
  • Figure 21: Global Autoinjectors Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2017-2031
  • Figure 22: Global Autoinjectors Market Revenue (US$ Mn), by Diabetes, 2017-2031
  • Figure 23: Global Autoinjectors Market Revenue (US$ Mn), by Anaphylaxsis, 2017-2031
  • Figure 24: Global Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 25: Global Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Global Autoinjectors Market Value Share Analysis, by Homecare Settings, 2022 and 2031
  • Figure 27: Global Autoinjectors Market Value Share Analysis, by Hospitals & Clinics, 2022 and 2031
  • Figure 28: Global Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 29: North America Autoinjectors Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 30: North America Autoinjectors Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 31: North America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 32: North America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 33: North America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 34: North America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 35: North America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 36: North America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 37: North America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 38: North America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 39: North America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Europe Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Europe Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Europe Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 45: Europe Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 46: Europe Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 48: Europe Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 50: Europe Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 51: Europe Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 52: Europe Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 53: Europe Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 55: Asia Pacific Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 56: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Asia Pacific Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 58: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 59: Asia Pacific Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 60: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Asia Pacific Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 62: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 63: Asia Pacific Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 64: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 65: Asia Pacific Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 66: Asia Pacific Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 67: Latin America Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 68: Latin America Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Latin America Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 70: Latin America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 71: Latin America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 72: Latin America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 73: Latin America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 74: Latin America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 75: Latin America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 76: Latin America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 77: Latin America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 78: Latin America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Latin America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 81: Middle East and Africa Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 82: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 83: Middle East and Africa Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 84: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 85: Middle East and Africa Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 86: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 87: Middle East and Africa Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 88: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 89: Middle East and Africa Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 90: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 91: Middle East and Africa Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 92: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 93: Company Share Analysis, 2022